New technology enables highest levels of accuracy at immense scale, with the power to sequence more than 20,000 genomes per year
Our most sustainable high-throughput sequencer delivers 90% reduction in packaging and 50% reduction in plastic waste, and eliminates dry ice shipments, expanding global access to genomic medicine
Needham sees Coinbase Global Inc (NASDAQ: COIN) well positioned for growth with expanding revenues driven by broader market sentiments and gave the stock a Buy rating and raised the price target from $160 to $180.